Clinical Trial Update: Correlation Between Regional Brain Volume and Response to Donepezil Treatment in AD Patients [Phase 4]

View source ↗

Summary

This Phase 4 trial update reports termination of a study examining whether regional brain volume predicts response to donepezil in Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Donepezil (donepezil)

Snippet

Sponsor: Eisai Korea Inc. | Conditions: Alzheimer's Disease | Phase 4 | Status: TERMINATED